Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is Graves' dermopathy a generalized disorder?

S R Peacey1, L Flemming, A Messenger

  • 1University Department of Medicine, Clinical Sciences Centre, Northern General Hospital, Sheffield, UK.

Thyroid : Official Journal of the American Thyroid Association
|February 1, 1996
PubMed
Summary

This study investigated subclinical Graves' dermopathy in forearm skin. Researchers found no evidence of mucin deposition or widespread fibroblast activation in Graves' disease patients, suggesting localized issues in affected areas.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frontal fibrosing alopecia: survey of severity assessment methods in routine clinical practice and validation of the International Frontal Fibrosing Alopecia Cooperative Group measurement guidance.

Clinical and experimental dermatology·2021
Same author

Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG).

The British journal of dermatology·2021
Same author

An update on the pathogenesis of Hashimoto's thyroiditis.

Journal of endocrinological investigation·2020
Same author

Frontal fibrosing alopecia: a descriptive cross-sectional study of 711 cases in female patients from the UK.

The British journal of dermatology·2020
Same author

Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Establishing and prioritizing research questions for the prevention, diagnosis and treatment of hair loss (excluding alopecia areata): the Hair Loss Priority Setting Partnership.

The British journal of dermatology·2017

Area of Science:

  • Endocrinology and Immunology
  • Dermatology
  • Histopathology

Background:

  • Graves' disease extrathyroidal manifestations, like Graves' ophthalmopathy and pretibial myxedema (Graves' dermopathy), are linked to fibroblast activation and mucin production.
  • The exact cause of fibroblast activation at these specific sites remains unclear, with conflicting evidence regarding generalized versus site-specific activation.
  • Previous research indicated increased glycosaminoglycan (GAG) deposition in forearm skin of Graves' disease patients without pretibial myxedema.

Purpose of the Study:

  • To investigate the presence of subclinical dermopathy in forearm skin of patients with untreated and treated Graves' disease.
  • To compare histological changes in forearm skin with normal controls, toxic nodular goiter patients, and those with established Graves' dermopathy.
  • To assess fibroblast activation and mucin/GAG deposition using specific histological stains and HLA-DR expression.

Related Experiment Videos

Main Methods:

  • Forearm skin biopsy specimens were analyzed from patients with untreated Graves' disease (UG), treated Graves' disease (TG), normal controls (C), toxic nodular goiter (MNG), and pretibial myxedema (PTM).
  • Histological examination included stains for mucin, elastin, glycosaminoglycans (GAGs) using colloidal iron and gold, and HLA-DR molecules via the CR3/43 antibody.
  • Quantitative and qualitative assessments of staining intensity and cellular infiltration were performed.

Main Results:

  • All PTM specimens showed positive mucin staining and varying elastin fiber patterns.
  • Heavy GAG staining was observed in most PTM specimens; however, no mucin deposition or elastin changes were found in UG, TG, MNG, or control groups.
  • Mild GAG staining was infrequent across all groups, and HLA-DR expression on dermal fibroblasts was noted in PTM but not significantly in forearm skin of Graves' disease patients.

Conclusions:

  • This study found no evidence of dermal mucin deposition or widespread fibroblast activation in the forearms of patients with Graves' disease.
  • The histological findings suggest that subclinical dermopathy, characterized by mucin deposition and fibroblast activation, is not a generalized feature in the forearm skin of Graves' disease patients.
  • The observed HLA-DR expression in pretibial myxedema specimens indicates localized fibroblast activation at the disease site, but not systemically in the forearm.